National
FDA Cancels Cipla Pune Unit Licence Over Reactin Plus Violations
Maharashtra FDA cancels Cipla's Pune C&F unit drug sale licence over Reactin Plus packaging, recall, storage and record-keeping violations.
Topic
medicine safety india
1 stories
